Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.20.4
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jan. 31, 2021
Jan. 31, 2020
Jan. 31, 2021
Jan. 31, 2020
Income Statement [Abstract]        
Revenue
Expenses:        
Research and development 8,915,381 6,055,218 18,714,740 11,485,031
General and administrative 2,110,696 7,468,375 5,351,429 11,886,660
Loss from operations (11,026,077) (13,523,593) (24,066,169) (23,371,691)
Other (expense) income, net (440) 46,768 (1,063) 128,697
Interest expense (4,722) (78) (10,856) (1,070)
Foreign currency exchange gain (loss), net 328,592 (154,672) 151,674 (147,995)
Loss before income taxes (10,702,647) (13,631,575) (23,926,414) (23,392,059)
Income tax expense 1,450 2,450 2,950 2,450
Net loss $ (10,704,097) $ (13,634,025) $ (23,929,364) $ (23,394,509)
Basic and diluted net loss per common share $ (0.37) $ (1.27) $ (0.86) $ (2.19)
Weighted average shares used in computing basic and diluted net loss per common share 28,676,719 10,712,022 27,723,948 10,680,281